Nm23 gene product expression in invasive breast cancer - Immunohistochemical analysis and clinicopathological correlation

Acta Oncologica

Volumn 41, Issue 4, 2002, Pages 355-361

  Belev, Borislav ^a   Alerić, Ivan ^a   Vrbanec, Damir ^a   Petrovečki, Mladen ^a   Unušic, Joško ^a   Jakić Razumović, Jasminka ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; HORMONES; PATIENT MONITORING; PROTEINS; TUMORS;

METASTATIC SUPPRESSORS;

GENES;

ESTROGEN RECEPTOR; GENE PRODUCT; NUCLEOSIDE DIPHOSPHATE KINASE; PROGESTERONE RECEPTOR; PROTEIN NM23; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036354295     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602760169406     Document Type: Article

References (33)

1. The role of cancer staging in evidence-based medicine
2. KAI1, a putative marker for metastatic potential in human breast cancer
3. Inhibition of cell motility after nm23 transfection of human and murine tumor cells
4. Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions
5. Evidence for a novel gene associated with low tumor metastatic potential
6. Differential gene expression in tumor metastasis: nm23
7. The human nm23/nucleoside diphosphate kinases
8. Nm23 and tumour metastatis: Basic and translational advances
9. Nm23: Unraveling its biological function in cell differentiation
10. Identification of a second human nm23 gene, nm23-H2
11. Chromosomal localization and nuceloside diphosphate kinase activity of human metastasis-suppressor genes nm23-1 and nm23-2
12. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme
13. Nucleoside diphosphate kinase: An old enzyme with new functions?
14. A serine phosphorylation of nm23, and not its nucleoside disphosphate kinase activity, correlates with suppression of tumor metastatic potential
15. Site-directed mutation of nm23-H1. Site-directed mutations of nm 23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro
16. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity
17. Nucleoside diphosphate kinase enzyme activity of nm23-H2/PuF is not required for its DNA binding and in vitro transcriptional function
18. Relationship of cytoplasmic and nuclear receptors and progesterone receptors in human breast cancer
19. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
20. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: Significance and implications in tumor biology
21. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinocopathologic correlation
22. Nm23-H1: Genetic alterations and expression patterns in tumor metastases
23. Nm23-1 H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma
24. Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer
25. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival and other prognostic factors: An immunohistochemical study
26. Nm23 anti-metastatic gene product expression in colorectal carcinoma
27. Suppressive role of metastasis-related nm23-H1 gene in human ovarian carcinomas: Association of high messenger RNA expression with lack of lymph node metastasis
28. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas
29. Nm23 expression in breast ductal carcinomas: A ten-year follow-up study in a uniform group of node-negative breast cancer patients
30. Immunohistochemical expression of p53, nm23-H1, Ki67 and DNA ploidy: Correlation with lymph node status and other clinical pathologic parameters in breast cancer
31. Nm-23, c-erbB2 and progesterone receptor expression in invasive breast cancer: Correlation with clinicopathologic parameters
32. P-glycoprotein, metallothionein and nm23 protein expression in breast carcinoma
33. Nm23 expression in human breast cancer: Correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique